Stocks股票 / Health Care / BIO

Bio-Rad Laboratories · Health Care

BIO US listed · USD美股 · 美元

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.Bio-Rad Laboratories, Inc. 是一家美国开发制造商,为生命科学研究和临床诊断市场提供专业科技产品。

Rate-sensitive利率敏感 Health Care S&P 400标普400中盘
$301.90
-$2.46 · -0.81%
52w low52周低 $237high $345
Extended — don't chase; wait for a pullback过度拉升 — 勿追高;等待回撤 You missed the bottoming entry — the low already formed and price is now extended (momentum is fading — the daily momentum is already rolling over). Don't…已错过筑底入场——低点已经形成,目前价格已拉伸(动量正在衰竭——日线动量已开始掉头向下)。不要追高;等待回调至 10 日均线或下一个周期低点。若已持有则继续持有。 Engine read引擎解读 · 2026-07-21

Price chart价格图表

daily · interactive日线 · 可交互 Open in Terminal打开终端
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。 Open the live chart in Terminal在终端中打开实时图表
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。 MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动

Technicals技术面

daily bars日线数据 · 2026-07-21
Momentum (RSI 14)动量(RSI 14) 57
Neutral zone中性区域
vs 50-day average相对50日均线 +4.9% above上方 Uptrend intact趋势完好
vs 200-day average相对200日均线 +2.4% above上方 Long trend up长期向上
Volatility波动率 58th percentile第58百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源,每晚更新。

Earnings财务业绩

next report下次财报 2026-07-30
10days to go天后公布

Estimates being cut预期下调

Financials财务数据

fiscal years财年
Revenue营业收入
$2.5B2020
$2.9B2021
$2.8B2022
$2.7B2023
$2.6B2024
$2.6B2025
5-yr growth5年复合增速 0.3%
Earnings per share每股收益
$126.202020
$140.562021
$-121.792022
$-21.822023
2024
$27.852025
5-yr growth5年复合增速 -26.1%
Free cash flow自由现金流
$476.4M2020
$535.7M2021
$81.7M2022
$218.3M2023
$289.6M2024
$374.6M2025
Gross margin毛利率
51.9%
Operating margin营业利润率
1.8%
Net margin净利率
29.4%
FCF margin自由现金流利润率
20.6%
Balance-sheet quality财务体质 4/8 Return on equity股本回报率 10% Watch关注

Leverage杠杆

Net debt / EBITDA净债务/EBITDA3.16
Current ratio流动比率5.62

Capital allocation资本配置

Buybacks (TTM)回购(TTM)$295.5M
Stock-based comp股权薪酬$58.0M

Why is it moving为何波动

6 checks · nightly六项检查 · 每晚
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Quiet — no confirmed driver平静 — 无明确驱动
Technical技术面 NEARING A HIGH → BOTTOMING接近高点 → 筑底中

Signal history信号历史

engine events引擎事件
BOTTOMING → NEARING A HIGH筑底中 → 接近高点 TAKE PROFITS. A daily bottoming setup did fire (swing low in, momentum turned up), but it's LATE — price is already extended above the cycle low (formed ~18 day(s) ago @ 270.32) and momentum is fading — the daily momentum is already rolling over. A momentum cross is a LAGGING confirmation: after a vertical run it only triggers once the move is mature, so the bottoming entry has already passed. This is a chase, not a fresh buy. Last cycle was left-translated (topped early) — a bearish structural tell止盈。日线筑底形态确实已经触发(摆动低点出现、动量转向上行),但为时已晚——价格已显著高于周期低点(约 18 天前形成 @ 270.32)且动量正在衰竭——日线动量已开始掉头向下。动量交叉属于滞后确认:在垂直拉升之后,只有当走势已经成熟时才会触发,因此筑底入场早已错过。这是追高,而非新的买入。 上一周期为左移结构(见顶偏早)——属于看空的结构性信号
Jul 16, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 15, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jul 13, 2026
BOTTOMING → UPTREND筑底中 → 上涨趋势
HOLD持有
Jul 10, 2026
UPTREND → BOTTOMING上涨趋势 → 筑底中
BUY SETUP买入预备
Jul 10, 2026
BIO daily MACD crossed upBIO 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $296.11.日线MACD柱状图转正 — 快速且嘈杂,仅作背景。$296.11。
Jul 9, 2026
NEARING A LOW → UPTREND接近低点 → 上涨趋势
HOLD持有
Jul 9, 2026
BIO reclaimed its 200-day averageBIO 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $297.28.收盘重回200日均线 — 经典的多头分界线。$297.28。
Jul 8, 2026
NEARING A HIGH → NEARING A LOW接近高点 → 接近低点
GET READY准备
Jul 8, 2026
BIO daily MACD crossed downBIO 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $283.86.日线MACD柱状图转负 — 快速且嘈杂,仅作背景。$283.86。
Jul 7, 2026
BIO lost its 200-day averageBIO 跌破200日均线
Price closed below the 200-day moving average — the classic bear dividing line. $292.50.收盘跌破200日均线 — 经典的空头分界线。$292.50。
Showing the last 15 of显示最近15条,共 248 signals条信号

Company profile公司档案

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.Bio-Rad Laboratories, Inc. 是一家美国开发制造商,为生命科学研究和临床诊断市场提供专业科技产品。

Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Profitability盈利能力
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Above market高于市场
Short interest空头兴趣
Below market低于市场

The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。

Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。

Browse all stocks浏览所有股票 Open Terminal打开终端

Research context only — not investment advice. Past patterns do not guarantee future results.仅供研究参考,不构成投资建议。历史规律不代表未来表现。

Data through数据截至 2026-07-21 · regenerated nightly每晚更新 · Generated生成于 2026-07-21 02:08 UTC · All coverage所有股票 · Analyzer分析器